Upstream Bio Inc.

NASDAQ: UPB · Real-Time Price · USD
18.95
0.33 (1.77%)
At close: Aug 15, 2025, 3:59 PM
19.00
0.29%
After-hours: Aug 15, 2025, 05:39 PM EDT

Upstream Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
2.72M 2.3M 2.37M 2.21M 2.22M 1.71M 1.07M 621K
Cost of Revenue
163K 106K 63K 14K n/a n/a n/a n/a
Gross Profit
2.72M 2.3M 2.37M 2.21M 2.22M 1.71M 1.07M 621K
Operating Income
-121.57M -94.76M -77.76M -65.78M -56.27M -38.73M -23.72M -9.39M
Interest Income
17.15M 15.6M 12.12M 8.57M 7.19M 4.31M 3.05M 1.53M
Pretax Income
-104.47M -79.18M -62.81M -53.4M -40.51M -25.83M -14.94M -3.1M
Net Income
-104.47M -79.18M -62.81M -53.4M -40.51M -25.83M -14.94M -3.1M
Selling & General & Admin
23.43M 19.99M 17.17M 15.24M 13.39M 9.41M 5.45M 2.22M
Research & Development
100.87M 77.07M 62.97M 52.75M 45.1M 31.03M 19.34M 7.79M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
124.29M 97.06M 80.13M 67.98M 58.49M 40.44M 24.79M 10.01M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
124.29M 97.06M 80.13M 67.98M 58.49M 40.44M 24.79M 10.01M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
53.77M 53.62M 51.34M 51.34M 51.34M 51.34M 36.32M 36.32M
Shares Outstanding (Diluted)
53.77M 53.62M 51.34M 51.34M 51.34M 51.34M 36.32M 36.32M
EPS (Basic)
-2.07 -1.71 -1.47 -1.47 -1.23 -0.85 -0.58 -0.17
EPS (Diluted)
-2.07 -1.71 -1.47 -1.47 -1.23 -0.85 -0.58 -0.17
EBITDA
-121.42M -94.64M -77.67M -65.72M -56.21M -38.69M -23.68M -9.37M
EBIT
-121.57M -94.76M -77.76M -65.78M -56.27M -38.73M -23.72M -9.39M
Depreciation & Amortization
148K 119K 89K 54K 57K 44K 31K 17K